Infliximab plus azathioprine is more effective than azathioprine alone in achieving mucosal healing in pediatric patients with Crohn's disease.
Jan MelekMarkéta ŠtanclováPetr DědekJan MalýMilan BayerOldřich PozlerJan BurešPublished in: Journal of digestive diseases (2021)
Combined therapy (IFX + AZA) was more effective in achieving MH in pediatric CD than treatment with AZA alone.